Total Funding
80
65
Total FundingSeries C raised
Growth Score 80 in past quarter
-4 pts
Heat Score 65 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
39540
MIT "touch tech" spinout. Diagnostic devices. Software and Hardware.
- Eric Keller: Co-Founder and Chief Strategy Officer
Arunas Chesonis: Chairman & DirectorPast Role: Cranberry Capital, Managing Partner
About the Company
Founded in 2013 as an MIT “Tough Tech” spinout, Hyperion Biosystems (formerly C2Sense, Inc.) has created a suite of diagnostic devices that leverage our expertise in computer vision and physics-based algorithms to deliver exquisite performance at the lowest price. Our exceptional team of scientists and engineers have years of experience
collaborating with market leaders in diagnostics and pharmaceuticals with the goal of minimizing the impact of disease and protecting people.